Skip to content
drillr.ai
Sign up

DNA

Ginkgo Bioworks Holdings, Inc.

NYSE · Healthcare · Biotechnology · US

$6.95
+0.00%
Ask drillr

  • Aug 8, 2026, 04:04 UTC

    Ginkgo Bioworks reported second-quarter 2026 revenue of $20 million, down 48% from the year-earlier period.

    Source: